Related Experiment Video
Updated: Jun 23, 2026
05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 27, 2013
Selection of patients with acute myocardial infarction for thrombolytic therapy
1University of Michigan Medical Center, Ann Arbor.
Annals of Internal Medicine
|December 15, 1990
Summary
Thrombolytic therapy significantly reduces mortality in eligible myocardial infarction patients. Expanding eligibility criteria to include selected high-risk subgroups, like elderly patients or those presenting later, could further improve outcomes.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Thrombolytic therapy is a critical treatment for acute myocardial infarction.
- Current eligibility criteria for thrombolysis may limit its widespread application and benefit.
Purpose of the Study:
- To critically review current recommendations for thrombolytic therapy eligibility in myocardial infarction patients.
- To assess the impact of current exclusion criteria on patient outcomes.
Main Methods:
- Systematic review of randomized controlled trials and observational studies published between 1980 and 1990.
- Analysis of patient eligibility, reasons for exclusion, and clinical outcomes.
- Examination of exclusion criteria validity using subgroup analyses.
Main Results:
- Few myocardial infarction patients are currently eligible for thrombolysis, despite significant mortality reduction in treated groups.
- Patients excluded from thrombolysis experience high early mortality.
- Selected high-risk subgroups, including elderly patients, those presenting later than 6 hours, and patients with controlled hypertension, may benefit from expanded eligibility.
Conclusions:
- Optimizing thrombolytic therapy requires continuous evaluation and refinement of selection criteria.
- Identifying and treating a broader range of eligible patients is essential to fully realize the potential of thrombolysis in altering myocardial infarction outcomes.
More Related Videos
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...